Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parkinson's disease and inflammatory changes.

Carlos Barcia1, Andrés Fernández Barreiro, Máximo Poza

  • 1Experimental Neurology and Neurosurgery Group, School of Medicine, Campus Espinardo, University of Murcia, 30071 Murcia, Spain. barcia@um.es

Neurotoxicity Research
|January 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Age- and sex-related development of osteosarcopenia in the aging <i>Octodon degus</i> rodent model.

Frontiers in aging·2025
Same author

A DTI-Radiomics and Clinical Integration Model for Predicting MCI-to-AD Progression Using Corpus Callosum Features.

Current Alzheimer research·2025
Same author

Age-defying swallowing.

Frontiers in aging·2025
Same author

Age- and sex-related development of osteosarcopenia in the aging <i>Octodon degus</i> rodent model.

Frontiers in aging·2025
Same author

Identification of Predictors of Sarcopenia in Older Adults Using Machine Learning: English Longitudinal Study of Ageing.

Journal of clinical medicine·2024
Same author

A Computer Vision-Based System to Help Health Professionals to Apply Tests for Fall Risk Assessment.

Sensors (Basel, Switzerland)·2024

Parkinson's disease involves brain inflammation, indicated by activated microglia and increased cytokines. Anti-inflammatory treatments show promise in animal models, potentially slowing neuronal loss in patients.

Area of Science:

  • Neuroscience
  • Immunology
  • Neuropathology

Background:

  • Microglial activation in the substantia nigra pars compacta (SNpc) and striatum is observed in Parkinson's disease (PD) brains.
  • Elevated cytokine levels in cerebrospinal fluid and post-mortem analyses suggest a chronic proinflammatory response in PD patients.
  • MPTP exposure has been linked to microglial activation in PD patients, indicating a potential environmental trigger.

Purpose of the Study:

  • To investigate the role of neuroinflammation in Parkinson's disease pathogenesis.
  • To explore the potential of anti-inflammatory therapies for Parkinson's disease.

Main Methods:

  • Review of studies on microglial activation and cytokine levels in Parkinson's disease patients and animal models.
  • Analysis of research on the effects of anti-inflammatory drugs in parkinsonian animal models.

Related Experiment Videos

Main Results:

  • Consistent evidence of microglial activation and inflammation in Parkinson's disease across human and animal studies.
  • Animal studies with anti-inflammatory drugs demonstrated promising outcomes in mitigating disease progression.
  • The precise role of inflammation (damaging vs. protective) in neurodegeneration remains unclear.

Conclusions:

  • Neuroinflammation is a key feature of Parkinson's disease, potentially contributing to or exacerbating neuronal loss.
  • Anti-inflammatory strategies warrant further investigation as a therapeutic approach for Parkinson's disease.
  • Understanding the dual role of inflammation is crucial for developing effective neuroprotective treatments.